Wednesday 17 January 2018 ShareProphets: The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

And the winner of the ShareProphets Cloudtag rebranding contest is...

By Tom Winnifrith | Monday 12 December 2016

Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.

Steve Moore has passed on the task of judging this contest since we had 96 entries including my own. As you can see HERE there were many splended suggestions as to what Cloudtag should rebrand its product as. But there can only be one winner of a golden ticket to the UK Investor Show incorporating a night at the Saracens cabaret.

Of course I hope that those who did not win will book a Golden Ticket and join us on March 29 and April 1 HERE

The winner? He would have sent a letter to the Guardian whinging and grumbling had he not won but his entry did win on merit as well. Well done Waseem Shakoor for:

I think you are all fools and are lacking in scale. If I was Amit, I wouldn't hesitate to call the product 'iHeart' as it suggests a tie-up with Apple. Not only would the lemmings at LSE lap this up, there is an obvious RNS that could be released off the back of it. When the first lawyer's letter landed on the desk from Apple (it'll take some time, so plenty of time for L1 to dump some more shares), CTAG will be able to truthfully issue an RNS to say that it is "in discussions with Apple". Cue hysteria amongst the CTAG loons.

Filed under:

Never miss a story.

This area of the site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.

More on CTAG


Comments are turned off for this article.

Site by Everywhen